Scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies
Long COVID-free, isolated Pacific islands hit with outbreaks
4 February 2022Spain to drop masks outdoors as omicron surge decelerates
4 February 2022Scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies
Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.
